Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:44 pm Purchase | 13G | Disc Medicine Inc. IRON | Bain Capital Life Sciences Opportunities III LP | 1,795,735 6.000% | 463,190 (+34.76%) | View |
| 2024-11-14 4:33 pm Sale | 13G | Disc Medicine Inc. IRON | Paradigm Biocapital Advisors LP | 1,497,720 5.040% | -888,137 (-37.23%) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | Disc Medicine Inc. IRON | BlackRock Inc. BLK | 1,851,171 6.200% | 0 (Unchanged) | View |
| 2024-11-08 10:52 am Purchase | 13G | Disc Medicine Inc. IRON | WELLINGTON MANAGEMENT GROUP LLP | 1,840,226 6.190% | 1,840,226 (New Position) | View |
| 2024-10-24 2:02 pm Purchase | 13G | Disc Medicine Inc. IRON | BlackRock Inc. BLK | 1,851,171 6.200% | 1,851,171 (New Position) | View |
| 2024-06-25 10:06 am Purchase | 13G | Disc Medicine Inc. IRON | Frazier Life Sciences Public Fund L.P. | 1,754,834 5.900% | 1,754,834 (New Position) | View |
| 2024-06-20 5:15 pm Purchase | 13D | Disc Medicine Inc. IRON | ORBIMED ADVISORS LLC | 1,785,571 6.000% | 83,334 (+4.90%) | View |
| 2024-06-20 4:01 pm Purchase | 13D | Disc Medicine Inc. IRON | AI DMI LLC | 3,762,507 12.600% | 416,667 (+12.45%) | View |
| 2024-02-14 4:08 pm Purchase | 13G | Disc Medicine Inc. IRON | Paradigm Biocapital Advisors LP | 2,385,857 9.900% | 1,149,939 (+93.04%) | View |
| 2024-02-13 6:51 pm Sale | 13G | Disc Medicine Inc. IRON | Bain Capital Life Sciences Opportunities III LP | 1,332,545 5.500% | -658,369 (-33.07%) | View |
| 2024-02-09 08:50 am Purchase | 13G | Disc Medicine Inc. IRON | FMR LLC | 2,166,819 8.975% | 24,095 (+1.12%) | View |
| 2024-02-07 07:24 am Sale | 13G | Disc Medicine Inc. IRON | ADAGE CAPITAL PARTNERS GP L.L.C. | 750,000 3.110% | -412,624 (-35.49%) | View |
| 2024-01-25 4:38 pm Sale | 13D | Disc Medicine Inc. IRON | Atlas Venture Fund X L.P. | 1,402,186 5.800% | -191,599 (-12.02%) | View |
| 2023-12-15 4:48 pm Sale | 13D | Disc Medicine Inc. IRON | ORBIMED ADVISORS LLC | 1,702,237 7.100% | -567,400 (-25.00%) | View |
| 2023-11-13 06:46 am Purchase | 13D | Disc Medicine Inc. IRON | AI DMI LLC | 3,345,840 13.740% | 204,081 (+6.50%) | View |
| 2023-09-25 4:56 pm Purchase | 13G | Disc Medicine Inc. IRON | Paradigm Biocapital Advisors LP | 1,235,918 5.400% | 1,235,918 (New Position) | View |
| 2023-09-21 4:44 pm Sale | 13D | Disc Medicine Inc. IRON | Atlas Venture Fund X L.P. | 1,593,785 7.000% | -643,518 (-28.76%) | View |
| 2023-06-30 4:30 pm Purchase | 13G | Disc Medicine Inc. IRON | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,162,624 5.240% | 812,562 (+232.12%) | View |
| 2023-06-28 5:22 pm Sale | 13G | Disc Medicine Inc. IRON | Novo Holdings A/S | 1,090,772 4.800% | -1,250,000 (-53.40%) | View |
| 2023-06-21 4:53 pm Purchase | 13D | Disc Medicine Inc. IRON | ORBIMED ADVISORS LLC | 2,269,637 10.200% | 108,696 (+5.03%) | View |